NYSE:NHI National Health Investors (NHI) Stock Price, News & Analysis → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free NHI Stock Alerts $62.61 -0.24 (-0.38%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$61.96▼$62.8050-Day Range$53.21▼$62.8552-Week Range$47.54▼$63.19Volume115,742 shsAverage Volume155,176 shsMarket Capitalization$2.72 billionP/E Ratio20.00Dividend Yield5.75%Price Target$60.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get National Health Investors alerts: Email Address National Health Investors MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside3.4% Downside$60.50 Price TargetShort InterestHealthy1.98% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-2.59Upright™ Environmental ScoreNews Sentiment0.31Based on 4 Articles This WeekInsider TradingAcquiring Shares$586,900 Bought Last QuarterProj. Earnings Growth4.61%From $4.34 to $4.54 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.55 out of 5 starsFinance Sector151st out of 848 stocksReal Estate Investment Trusts Industry28th out of 177 stocks 2.3 Analyst's Opinion Consensus RatingNational Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageNational Health Investors has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.98% of the float of National Health Investors has been sold short.Short Interest Ratio / Days to CoverNational Health Investors has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in National Health Investors has recently decreased by 6.48%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend LeadershipNational Health Investors is a leading dividend payer. It pays a dividend yield of 5.74%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNational Health Investors does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Health Investors is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, National Health Investors will have a dividend payout ratio of 79.30% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNational Health Investors has received a 57.12% net impact score from Upright. National Health Investors seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is driven by its "Real estate funds investing in residential care centers" and "Real estate funds investing in health centers" products. See details.Environmental SustainabilityThe Environmental Impact score for National Health Investors is -2.59. Previous Next 2.4 News and Social Media Coverage News SentimentNational Health Investors has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 4 news articles for National Health Investors this week, compared to 2 articles on an average week.Search Interest9 people have searched for NHI on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added National Health Investors to their MarketBeat watchlist in the last 30 days. This is a decrease of -63% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Health Investors insiders have bought more of their company's stock than they have sold. Specifically, they have bought $586,900.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 7.26% of the stock of National Health Investors is held by insiders.Percentage Held by Institutions62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for National Health Investors are expected to grow by 4.61% in the coming year, from $4.34 to $4.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Health Investors is 20.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 148.31.Price to Earnings Ratio vs. SectorThe P/E ratio of National Health Investors is 20.00, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 63.38.Price to Book Value per Share RatioNational Health Investors has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About National Health Investors Stock (NYSE:NHI)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.Read More NHI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NHI Stock News HeadlinesApril 26, 2024 | bizjournals.comA focus to changeApril 21, 2024 | americanbankingnews.comNational Health Investors (NYSE:NHI) & Paramount Group (NYSE:PGRE) Critical ContrastApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!April 18, 2024 | msn.comActivist Land & Buildings plans to vote against two National Health Investors directorsApril 18, 2024 | businesswire.comLand & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual MeetingApril 18, 2024 | americanbankingnews.comNational Health Investors (NYSE:NHI) Downgraded by StockNews.comApril 17, 2024 | finance.yahoo.comAnnoviant™ Awarded $2.99 Million NIH Grant to Advance TxGuard™ Pulmonary-Valved Conduit for Pediatric Heart DiseaseApril 12, 2024 | finanznachrichten.deNational Health Investors: NHI Announces First Quarter 2024 Earnings Release and Conference Call DateApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!April 4, 2024 | benzinga.comDeep Dive Into National Health Investors Stock: Analyst Perspectives (6 Ratings)March 28, 2024 | msn.comMetyos raises €2.3m to boost wearable kidney disease deviceMarch 20, 2024 | incomeinvestors.comNational Health Investors Stock at 52-Week High: More Gains to Come?March 18, 2024 | finance.yahoo.comCanadian Diplomats Dispute Havana Study FindingsMarch 18, 2024 | ca.finance.yahoo.comNational home sales in February up nearly 20% compared with year agoMarch 14, 2024 | finance.yahoo.comTempus Contributes De-Identified Cancer Data to Planned Data EnclaveMarch 12, 2024 | msn.comLooking for non-dilutive funding? 5 tips for startups seeking small business grantsMarch 12, 2024 | benzinga.comSenior Housing Sector Is Reviving, Analyst Forecasts Growth For National Health InvestorsMarch 12, 2024 | markets.businessinsider.comOptimistic Buy Rating for National Health Investors on Strong SHOP Performance and Strategic AcquisitionsMarch 7, 2024 | finance.yahoo.comSeeking up to 8.5% Dividend Yield? Well Fargo Suggests 2 Dividend Stocks to BuyMarch 6, 2024 | morningstar.comNational Health Investors IncFebruary 27, 2024 | msn.comWedbush Upgrades National Health Investors (NHI)February 26, 2024 | seekingalpha.comNational Health Investors raised to Outperform at Wedbush on SNF strengthFebruary 26, 2024 | msn.comOmega Healthcare, National Health Investors upgraded to Overweight at Wells FargoFebruary 23, 2024 | seekingalpha.comNational Health: Lots To Love, But Valuation Still On The High SideFebruary 22, 2024 | benzinga.comNational Health Investors Stock (NYSE:NHI) Insider TradesFebruary 22, 2024 | finance.yahoo.comQ4 2023 National Health Investors Inc Earnings CallFebruary 22, 2024 | finance.yahoo.comNational Health Investors, Inc. (NYSE:NHI) Q4 2023 Earnings Call TranscriptSee More Headlines Receive NHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2022Ex-Dividend for 1/26 Dividend12/28/2023Dividend Payable1/26/2024Ex-Dividend for 5/3 Dividend3/27/2024Today4/25/2024Dividend Payable5/03/2024Next Earnings (Confirmed)5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Real estate investment trusts Sub-IndustrySpecialized REITs Current SymbolNYSE:NHI CUSIP63633D10 CIK877860 Webwww.nhireit.com Phone(615) 890-9100Fax615-225-3030Employees26Year Founded1991Price Target and Rating Average Stock Price Target$60.50 High Stock Price Target$69.00 Low Stock Price Target$52.00 Potential Upside/Downside-3.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$3.13 Trailing P/E Ratio20.00 Forward P/E Ratio14.43 P/E GrowthN/ANet Income$135.65 million Net Margins42.40% Pretax Margin42.02% Return on Equity10.65% Return on Assets5.41% Debt Debt-to-Equity Ratio0.90 Current Ratio10.27 Quick Ratio10.27 Sales & Book Value Annual Sales$319.83 million Price / Sales8.50 Cash Flow$4.88 per share Price / Cash Flow12.82 Book Value$29.13 per share Price / Book2.15Miscellaneous Outstanding Shares43,420,000Free Float40,272,000Market Cap$2.72 billion OptionableOptionable Beta0.95 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. D. Eric Mendelsohn (Age 62)President, CEO & Director Comp: $1.38MMr. John L. Spaid (Age 64)Executive VP of Finance, CFO & Treasurer Comp: $809.9kMr. Kevin Carlton Pascoe (Age 43)Executive VP & Chief Investment Officer Comp: $702.16kMr. David Louis Travis (Age 49)Senior VP & Chief Accounting Officer Comp: $534.9kMs. Kristin Sallee Gaines (Age 52)Senior VP & Chief Transaction Officer Comp: $570.9kMr. Dana Rolfson HamblyDirector of Investor RelationsMr. Kimberly OuimetDirector of Corporate Compliance & Human ResourcesMs. Michelle R. KellySenior Vice President of InvestmentsSusan V. SidwellCorporate SecretaryMs. Colleen SchallerReal Estate Transaction ManagerMore ExecutivesKey CompetitorsMedical Properties TrustNYSE:MPWEPR PropertiesNYSE:EPRDiamondRock HospitalityNYSE:DRHPebblebrook Hotel TrustNYSE:PEBRLJ Lodging TrustNYSE:RLJView All CompetitorsInsiders & InstitutionsSchnieders Capital Management LLCSold 360 shares on 4/25/2024Ownership: 0.026%Equitable Trust Co.Bought 4,940 shares on 4/25/2024Ownership: 0.011%Albert D Mason Inc.Bought 3,395 shares on 4/25/2024Ownership: 0.008%Raymond James Financial Services Advisors Inc.Sold 4,816 shares on 4/23/2024Ownership: 0.060%Sumitomo Mitsui Trust Holdings Inc.Bought 36,653 shares on 4/19/2024Ownership: 0.939%View All Insider TransactionsView All Institutional Transactions NHI Stock Analysis - Frequently Asked Questions Should I buy or sell National Health Investors stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NHI shares. View NHI analyst ratings or view top-rated stocks. What is National Health Investors' stock price target for 2024? 8 Wall Street research analysts have issued 1-year price objectives for National Health Investors' stock. Their NHI share price targets range from $52.00 to $69.00. On average, they expect the company's stock price to reach $60.50 in the next twelve months. This suggests that the stock has a possible downside of 3.4%. View analysts price targets for NHI or view top-rated stocks among Wall Street analysts. How have NHI shares performed in 2024? National Health Investors' stock was trading at $55.85 at the beginning of the year. Since then, NHI shares have increased by 12.1% and is now trading at $62.61. View the best growth stocks for 2024 here. When is National Health Investors' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our NHI earnings forecast. How can I listen to National Health Investors' earnings call? National Health Investors will be holding an earnings conference call on Tuesday, May 7th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were National Health Investors' earnings last quarter? National Health Investors, Inc. (NYSE:NHI) released its quarterly earnings data on Monday, May, 9th. The real estate investment trust reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to analyst estimates of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 10.65% and a net margin of 42.40%. The company's revenue was down 11.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.24 EPS. How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors? National Health Investors declared a quarterly dividend on Tuesday, February 20th. Stockholders of record on Thursday, March 28th will be given a dividend of $0.90 per share on Friday, May 3rd. This represents a $3.60 annualized dividend and a dividend yield of 5.75%. The ex-dividend date of this dividend is Wednesday, March 27th. Read our dividend analysis for NHI. Is National Health Investors a good dividend stock? National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 5.74%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 79.30% in the coming year. This indicates that the company may not be able to sustain their current dividend. Read our dividend analysis for NHI. What ETFs hold National Health Investors' stock? ETFs with the largest weight of National Health Investors (NYSE:NHI) stock in their portfolio include Global X SuperDividend REIT ETF (SRET), Principal Real Estate Active Opportunities ETF (BYRE), Global SuperDividend US ETF (DIV), First Trust Multi-Asset Diversified Income Index Fund (MDIV), iShares Residential and Multisector Real Estate ETF (REZ) and WisdomTree U.S. SmallCap Dividend Fund (DES).JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE) and What guidance has National Health Investors issued on next quarter's earnings? National Health Investors issued an update on its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share (EPS) guidance of 4.310-4.370 for the period, compared to the consensus estimate of 4.330. The company issued revenue guidance of -. What other stocks do shareholders of National Health Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO). Who are National Health Investors' major shareholders? National Health Investors' stock is owned by many different institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.94%), Nepsis Inc. (0.13%), Pensionfund DSM Netherlands (0.09%), Raymond James Financial Services Advisors Inc. (0.06%), Pensionfund Sabic (0.04%) and Schnieders Capital Management LLC (0.03%). Insiders that own company stock include Charlotte A Swafford, James R Jobe, Robert G Adams and Robert T Webb. View institutional ownership trends. How do I buy shares of National Health Investors? Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:NHI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Health Investors, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.